Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 14, 2021 at 04:29 am EDT
Share
Guanhao Biotech Co.,Ltd. announced earnings results for the nine months ended September 30, 2021. For the nine months, the company announced sales was CNY 371.991 million compared to CNY 319.051 million a year ago. Operating income was CNY 66.667 million compared to CNY 49.177 million a year ago. Net income was CNY 59.778 million compared to CNY 36.860 million a year ago. Basic earnings per share from continuing operations was CNY 0.23 compared to CNY 0.14 a year ago.
Guanhao Biotech Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services.
GUANHAO BIOTECH CO.,LTD. 
